<?xml version="1.0" encoding="UTF-8"?><rss version="2.0" xmlns:content="http://purl.org/rss/1.0/modules/content/"><channel><title>E药经理人 | wechat-feeds</title><link>http://MjM5NzY2MDQwMg.favicon.privacyhide.com/favicon.ico</link><description>我们致力于成为医药行业意见领袖平台，我们记录和观察医药重大商业事件，展现这个行业的复杂和冲突，提供最前线的思想火花。</description><managingEditor> (hellodword)</managingEditor><pubDate>Tue, 16 Feb 2021 17:03:42 +0800</pubDate><image><url>http://MjM5NzY2MDQwMg.favicon.privacyhide.com/favicon.ico</url><title>E药经理人 | wechat-feeds</title><link>http://MjM5NzY2MDQwMg.favicon.privacyhide.com/favicon.ico</link><width>64</width><height>64</height></image><item><title>信达刘勇军：新药临床转化效率与策略决定其上市进度与商业价值</title><link>https://mp.weixin.qq.com/s/o-D52dHWQft96iGlE8dkcg</link><description></description><content:encoded><![CDATA[<img src="http://mmbiz.qpic.cn/sz_mmbiz_jpg/bASSOTgOKeJwe69ebwTM3SsV6HxBcl95zFYgibbD0iaqxZGO66OOwXRYzPJoU0qndf80MYSKQrz2YZR0UdDEWcMw/0?wx_fmt=jpeg" referrerpolicy="no-referrer"><br>E药经理人]]></content:encoded><pubDate>Tue, 16 Feb 2021 15:05:41 +0800</pubDate></item><item><title>康宁杰瑞徐霆：真正“卡脖子”底层技术有很多没有解决，从关键试剂耗材到核心装备……</title><link>https://mp.weixin.qq.com/s/1NpndHLNHaC0e1bxXNxOrQ</link><description></description><content:encoded><![CDATA[<img src="http://mmbiz.qpic.cn/sz_mmbiz_jpg/bASSOTgOKeJwe69ebwTM3SsV6HxBcl95W1NT96U73gp6IqsT2sg0VRnt8gibUTC17HqTcfajl2Q4BPGLR0jDKwg/0?wx_fmt=jpeg" referrerpolicy="no-referrer"><br>E药经理人]]></content:encoded><pubDate>Tue, 16 Feb 2021 15:05:41 +0800</pubDate></item><item><title>和黄苏慰国：中国创新药公司真正走向国际市场要拿得出过硬的产品</title><link>https://mp.weixin.qq.com/s/QPZ1b6DFS0y8z1nsd6cd3g</link><description></description><content:encoded><![CDATA[<img src="http://mmbiz.qpic.cn/sz_mmbiz_jpg/bASSOTgOKeJwe69ebwTM3SsV6HxBcl957qiaic8zOafxYMUov2s7fJUlicTjpoOQKqqvUJWWbrsm6MWfqpbibbLzUQ/0?wx_fmt=jpeg" referrerpolicy="no-referrer"><br>E药经理人]]></content:encoded><pubDate>Tue, 16 Feb 2021 15:05:41 +0800</pubDate></item><item><title>荣昌房健民：走向First-in-class必须有一个有利于原始创新的新药研发环境</title><link>https://mp.weixin.qq.com/s/4JWs2Z3jyXNZbepwMvUM-Q</link><description></description><content:encoded><![CDATA[<img src="http://mmbiz.qpic.cn/sz_mmbiz_jpg/bASSOTgOKeJwe69ebwTM3SsV6HxBcl95ncUiazjWneTgDwEibqsSEwEWibVTaQQn8ibBE2SWiaY3qibZXiaCAskPIAfNA/0?wx_fmt=jpeg" referrerpolicy="no-referrer"><br>E药经理人]]></content:encoded><pubDate>Tue, 16 Feb 2021 15:05:41 +0800</pubDate></item><item><title>优卡迪俞磊：“原创药”专利是创新药企亟需突破的关键，而资金、良好的竞争机制和创新药的生态环境，是助推的必要条件</title><link>https://mp.weixin.qq.com/s/vc7CvAgGiINGuHZ4By5eYQ</link><description></description><content:encoded><![CDATA[<img src="http://mmbiz.qpic.cn/sz_mmbiz_jpg/bASSOTgOKeJwe69ebwTM3SsV6HxBcl95vNDpzMXmT5zuD3jyODH2ODAY3IcaVHyCXTRL5ca4L5iaFYibC8wUrzIQ/0?wx_fmt=jpeg" referrerpolicy="no-referrer"><br>E药经理人]]></content:encoded><pubDate>Tue, 16 Feb 2021 15:05:41 +0800</pubDate></item><item><title>何如意：license in产品该如何实现快速上市？药企出海临床试验设计该怎么做？一个最佳的临床是怎样的？</title><link>https://mp.weixin.qq.com/s/WJehGQgRwwPzPXaTqnPRAg</link><description></description><content:encoded><![CDATA[<img src="http://mmbiz.qpic.cn/sz_mmbiz_jpg/bASSOTgOKeIeJ4oQoeM0haUTib9TapcYGjxKKj5SFdiaUgmHEjVVP5vkYxHBmTA8RYPUY10FWzQw1ad3tNXqMwXg/0?wx_fmt=jpeg" referrerpolicy="no-referrer"><br>E药经理人]]></content:encoded><pubDate>Mon, 15 Feb 2021 13:25:06 +0800</pubDate></item><item><title>贝达丁列明：中国医药创新还有很多“卡脖子”的技术需要突破</title><link>https://mp.weixin.qq.com/s/nu3TsfD5VLkJdnbfDuRXsw</link><description></description><content:encoded><![CDATA[<img src="http://mmbiz.qpic.cn/sz_mmbiz_jpg/bASSOTgOKeIeJ4oQoeM0haUTib9TapcYGWiaRiblThlTbBMoscGbhic6LCZC4JzQx9peWVMaBoRLD6xticRGqvR66dA/0?wx_fmt=jpeg" referrerpolicy="no-referrer"><br>E药经理人]]></content:encoded><pubDate>Mon, 15 Feb 2021 13:25:06 +0800</pubDate></item><item><title>君实生物段鑫：不要盲目追求热门药物的License-in</title><link>https://mp.weixin.qq.com/s/x086eLILm_lhNBDXqMD6Ig</link><description></description><content:encoded><![CDATA[<img src="http://mmbiz.qpic.cn/sz_mmbiz_jpg/bASSOTgOKeIeJ4oQoeM0haUTib9TapcYGnyPMWtqqwHSDCKf25L5oSM0AQUWHjQQlFPiaN710VibpNlhnwDNQ4CzQ/0?wx_fmt=jpeg" referrerpolicy="no-referrer"><br>E药经理人]]></content:encoded><pubDate>Mon, 15 Feb 2021 13:25:06 +0800</pubDate></item><item><title>康方夏瑜：药物创新的目标是患者获益，这与支付方式改革方向始终一致</title><link>https://mp.weixin.qq.com/s/r6ZjqFPyGMtI2sfSiLzUdQ</link><description></description><content:encoded><![CDATA[<img src="http://mmbiz.qpic.cn/sz_mmbiz_jpg/bASSOTgOKeIeJ4oQoeM0haUTib9TapcYGoViceMhsXtAibOR5IRaJXib3PwZgEMaqYIktThRDAib10hB87TsmzvhxSg/0?wx_fmt=jpeg" referrerpolicy="no-referrer"><br>E药经理人]]></content:encoded><pubDate>Mon, 15 Feb 2021 13:25:06 +0800</pubDate></item><item><title>中药如何集采？哪些品种会纳入？质量层次如何划分?会不会沦为只看价格？</title><link>https://mp.weixin.qq.com/s/2whs4wl5qe50pMkO-e3n1A</link><description></description><content:encoded><![CDATA[<img src="http://mmbiz.qpic.cn/sz_mmbiz_jpg/bASSOTgOKeIeJ4oQoeM0haUTib9TapcYGVypVyaTqTELSGkbn2FxkHKhgwPalrMz9L7lfAN5SZI0naTVrLI44qQ/0?wx_fmt=jpeg" referrerpolicy="no-referrer"><br>E药经理人]]></content:encoded><pubDate>Sun, 14 Feb 2021 10:57:14 +0800</pubDate></item><item><title>征集丨医药人的声音！</title><link>https://mp.weixin.qq.com/s/9Va0gXn0lCEF8iAq8K1NwQ</link><description></description><content:encoded><![CDATA[<img src="http://mmbiz.qpic.cn/sz_mmbiz_jpg/bASSOTgOKeInqBqHnlP5uCYMiasJIh34WbicWOz1rpMVSH86p2GCPibv7Vsibe8SxXOHzicibAvtD20Ps0HTVicpNjN1A/0?wx_fmt=jpeg" referrerpolicy="no-referrer"><br>E药经理人]]></content:encoded><pubDate>Sun, 14 Feb 2021 10:57:14 +0800</pubDate></item><item><title>宴开一千三百余席，楚天科技留岗员工欢度除夕</title><link>https://mp.weixin.qq.com/s/FHDtt_GYybcB2vCn7hz1nw</link><description></description><content:encoded><![CDATA[<img src="http://mmbiz.qpic.cn/sz_mmbiz_jpg/bASSOTgOKeIeJ4oQoeM0haUTib9TapcYGWQhZoEVFd7VpONZ9C09s80xx8346xe4YlAGjQU6y4u7Temyr9yxSkQ/0?wx_fmt=jpeg" referrerpolicy="no-referrer"><br>E药经理人]]></content:encoded><pubDate>Sun, 14 Feb 2021 10:57:14 +0800</pubDate></item><item><title>2月21日邀您免费观看2021中国医药产业新年展望会·线上深度版</title><link>https://mp.weixin.qq.com/s/2myu2RG3LPRVeIDTFhclyw</link><description></description><content:encoded><![CDATA[<img src="http://mmbiz.qpic.cn/sz_mmbiz_jpg/bASSOTgOKeIlXJAqLB13vVplXWCLZFpKRaiaGQpLiaN2ibpdxjJJqhHtqicwPoBmMAo2wYmFSDN5hMMMf2WcnpRGDw/0?wx_fmt=jpeg" referrerpolicy="no-referrer"><br>E药经理人]]></content:encoded><pubDate>Sun, 14 Feb 2021 10:57:14 +0800</pubDate></item><item><title>陪跑11年回报近百倍，Moderna投资人为什么能成功？中美医药投资有哪些差异？详解美国四类投资模式</title><link>https://mp.weixin.qq.com/s/PhdhlmVmoIstnowitw2-2Q</link><description></description><content:encoded><![CDATA[<img src="http://mmbiz.qpic.cn/sz_mmbiz_jpg/bASSOTgOKeKgNNicPwdMAWhTw2Qp4pcHwtIg0iaSBMzEffId2qKdmR44icpCRYKKIu2pOg3Mq5AibyGPMGNibCibXWNw/0?wx_fmt=jpeg" referrerpolicy="no-referrer"><br>E药经理人]]></content:encoded><pubDate>Sat, 13 Feb 2021 11:37:39 +0800</pubDate></item><item><title>大总结！2020医疗上市公司对外投资减少，华润、海正领跑，西药与生物科技数量最多</title><link>https://mp.weixin.qq.com/s/Lo9PAmuuUBGmekdVG2_OLg</link><description></description><content:encoded><![CDATA[<img src="http://mmbiz.qpic.cn/sz_mmbiz_jpg/bASSOTgOKeKgNNicPwdMAWhTw2Qp4pcHwTOF6qIEur5AkB9ENC3lBTuXaU4v2kVxSYibSWtVrwAcqKlYLyxcO0iaw/0?wx_fmt=jpeg" referrerpolicy="no-referrer"><br>E药经理人]]></content:encoded><pubDate>Sat, 13 Feb 2021 11:37:39 +0800</pubDate></item><item><title>征集丨医药人的声音！</title><link>https://mp.weixin.qq.com/s/k8UdKolUSUvXnUlfoRS1Vw</link><description></description><content:encoded><![CDATA[<img src="http://mmbiz.qpic.cn/sz_mmbiz_jpg/bASSOTgOKeInqBqHnlP5uCYMiasJIh34WbicWOz1rpMVSH86p2GCPibv7Vsibe8SxXOHzicibAvtD20Ps0HTVicpNjN1A/0?wx_fmt=jpeg" referrerpolicy="no-referrer"><br>E药经理人]]></content:encoded><pubDate>Sat, 13 Feb 2021 11:37:39 +0800</pubDate></item><item><title>2月21日邀您免费观看2021中国医药产业新年展望会·线上深度版</title><link>https://mp.weixin.qq.com/s/OUFRKhHoQxfV1YeBh7Ygxg</link><description></description><content:encoded><![CDATA[<img src="http://mmbiz.qpic.cn/sz_mmbiz_jpg/bASSOTgOKeIlXJAqLB13vVplXWCLZFpKRaiaGQpLiaN2ibpdxjJJqhHtqicwPoBmMAo2wYmFSDN5hMMMf2WcnpRGDw/0?wx_fmt=jpeg" referrerpolicy="no-referrer"><br>E药经理人]]></content:encoded><pubDate>Sat, 13 Feb 2021 11:37:39 +0800</pubDate></item><item><title>高光时刻！2021中国医药创新：BigPharma、Biopharma、Biotech交相辉映，国际化进程势不可挡</title><link>https://mp.weixin.qq.com/s/Zuk5LNt-qnd7XZrvY-qF2A</link><description></description><content:encoded><![CDATA[<img src="http://mmbiz.qpic.cn/sz_mmbiz_jpg/bASSOTgOKeKgNNicPwdMAWhTw2Qp4pcHwrDr7u0Pjofa0mX1zKrw3hRDW6oOYLg1y0BpZ0gcRMt5oib9nQRMnUrA/0?wx_fmt=jpeg" referrerpolicy="no-referrer"><br>E药经理人]]></content:encoded><pubDate>Fri, 12 Feb 2021 17:31:16 +0800</pubDate></item><item><title>我们应该信仰什么？</title><link>https://mp.weixin.qq.com/s/HhNR87GxQbtHbmN1ejgiBQ</link><description></description><content:encoded><![CDATA[<img src="http://mmbiz.qpic.cn/sz_mmbiz_jpg/bASSOTgOKeKgNNicPwdMAWhTw2Qp4pcHwVJNiakGkA9LhDm7pwNEiakwdLHWESKUPI9b0HJPIrA2G1C7W1wjc9Libg/0?wx_fmt=jpeg" referrerpolicy="no-referrer"><br>E药经理人]]></content:encoded><pubDate>Fri, 12 Feb 2021 17:31:16 +0800</pubDate></item><item><title>征集丨医药人的声音！</title><link>https://mp.weixin.qq.com/s/pVxAMyvy2oeP23pFlDZeow</link><description></description><content:encoded><![CDATA[<img src="http://mmbiz.qpic.cn/sz_mmbiz_jpg/bASSOTgOKeInqBqHnlP5uCYMiasJIh34WbicWOz1rpMVSH86p2GCPibv7Vsibe8SxXOHzicibAvtD20Ps0HTVicpNjN1A/0?wx_fmt=jpeg" referrerpolicy="no-referrer"><br>E药经理人]]></content:encoded><pubDate>Fri, 12 Feb 2021 17:31:16 +0800</pubDate></item></channel></rss>